Search filters

List of works by Olaf Stüve

200 years after Darwin

scientific article published in February 2009

A 69-year-old man with left hemispheric necrotizing mass lesion

scientific article published in July 2009

A bird's-eye view of T cells during natalizumab therapy

scientific article published on 18 September 2013

A critical appraisal of treatment decisions in multiple sclerosis—old versus new ⬇️

scientific article published on 05 April 2011

A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis

scientific article

Acute disseminated encephalomyelitis: an acute hit against the brain

scientific article

Acute disseminated encephalomyelitis: an update

scientific article

Alemtuzumab: the advantages and challenges of a novel therapy in MS.

scientific article

Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease

scientific article

Anti-Glutamic Acid Decarboxylase Antibody-Associated Ataxia as an Extrahepatic Autoimmune Manifestation of Hepatitis C Infection: A Case Report ⬇️

scientific article published on July 10, 2011

Approved and future pharmacotherapy for multiple sclerosis

scientific article

Are statins a treatment option for multiple sclerosis?

scientific article published on June 2004

B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets.

scientific article published on 21 March 2018

B cell-directed therapies in multiple sclerosis

scientific article

B cells, antibodies, and tertiary lymphoid tissue in MS brains

scientific article published in September 2008

B-cell-targeted therapies in relapsing forms of MS.

scientific article published on 23 October 2017

CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke ⬇️

scientific article published on February 16, 2012

CD19 as a molecular target in CNS autoimmunity

scientific article

CNS Intravascular Lymphoma: A Case Report ⬇️

scientific article published on September 7, 2011

Central nervous system infections - a potential complication of systemic immunotherapy

scientific article

Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis ⬇️

scientific article published on July 11, 2011

Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice

scientific article published on June 2007

Corticosteroids for multiple sclerosis: I. Application for treating exacerbations

scientific article published on October 2007

Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects

scientific article published on October 2007

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

scientific article

Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects

scientific article published on January 2012

Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate

scientific article published in September 2002

DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation

scientific article published on 6 April 2011

DNA plasmid vaccination for multiple sclerosis

scientific article

DNA-based vaccines: the future of multiple sclerosis therapy?

scientific article published on March 2008

Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab

scientific article

Defining standard enzymatic dissociation methods for individual brains and spinal cords in EAE.

scientific article

Defining the clinical course of multiple sclerosis: the 2013 revisions

scientific article

Depletion of B lymphocytes from cerebral perivascular spaces by rituximab

scientific article published on August 2009

Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity ⬇️

scientific article published on June 3, 2013

Direct and consensual murine pupillary reflex metrics: establishing normative values

scientific article published on 15 August 2009

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses

scientific article

Disease-modifying agents for multiple sclerosis: recent advances and future prospects

scientific article published on January 2008

Does natalizumab therapy benefit patients with multiple sclerosis?

scientific article published in August 2014

Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?

scientific article published on 8 May 2014

Emerging drugs for primary progressive multiple sclerosis

scientific article published on 11 April 2018

Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles

scientific article published on January 2005

Evolution of clinical trials in multiple sclerosis

Factors that influence adherence with disease-modifying therapy in MS.

scientific article published on 27 April 2009

From injection therapies to natalizumab: views on the treatment of multiple sclerosis

scientific article published in March 2012

Genetic polymorphism at codon 129 of the prion protein gene is not associated with multiple sclerosis

scientific article published in February 2009

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report

scientific article published on February 2015

Human aquaporin 4281-300 is the immunodominant linear determinant in the context of HLA-DRB1*03:01: relevance for diagnosing and monitoring patients with neuromyelitis optica

scientific article published on September 2012

Humoral immune responses after rabies infection

scientific article published in September 2007

IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation

scientific article

Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine

scientific article

Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles,Pathophysiology and Therapeutic Choices ⬇️

scientific article published on September 1, 2011

Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis

scientific article

Immune surveillance in multiple sclerosis patients treated with natalizumab.

scientific article

Immune-mediated CNS diseases: A review on nosological classification and clinical features ⬇️

scientific article published on May 18, 2011

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity

scientific article

Immunomodulatory treatment strategies in multiple sclerosis

scientific article published on December 2008

Immunopathogenesis of multiple sclerosis: new insights and therapeutic implications ⬇️

scientific article published on October 1, 2010

Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis: in search of biomarkers

scientific article published on July 2014

Immunosuppression in clinical practice: approaches to individualized therapy

scientific article published on December 2008

In Memoriam: Jean Lindenmann (1924-2015): A Circuitous Interfering Power in Neurology

scientific article published on June 2015

In Memoriam: John F. Kurtzke, MD (1926-2015): A Founding Father of Neuroepidemiology and Pioneer of Modern Clinical Trial Design

scientific article published in April 2016

Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis

scientific article published in November 2006

Isoniazid in autoimmunity: a trigger for multiple sclerosis?

scientific article

Knowns and unknowns in the future of multiple sclerosis treatment

scientific article

Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's disease

scientific article

Long-term B-lymphocyte depletion with rituximab in patients with relapsing-remitting multiple sclerosis

scientific article published in February 2009

Lymph node-derived donor encephalitogenic CD4+T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet ⬇️

scientific article published on June 24, 2011

Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment—Past, Present, and Future Aspects ⬇️

scientific article published on June 1, 2013

Managing Disability in Progressive Multiple Sclerosis

scientific article published on June 2016

Mitoxantrone as a potential therapy for primary progressive multiple sclerosis

scientific article published in June 2004

Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis

scientific article published on January 2008

Multiple sclerosis and chronic cerebrospinal venous insufficiency: a critical review ⬇️

scientific article published on July 1, 2011

Multiple sclerosis disease progression and paradichlorobenzene: a tale of mothballs and toilet cleaner

scientific article published in February 2014

Multiple sclerosis in the elderly patient

scientific article published on April 2010

Multiple sclerosis therapy: an update on recently finished trials

scientific article published on 15 November 2007

Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro

scientific article published in November 2005

Multiple sclerosis: combination therapy in MS--still a valid strategy

scientific article

Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?

scientific article published on August 2010

Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational Neuroimmunology

scientific article published on February 2017

Natalizumab: increased vigilance is required in treating patients with multiple sclerosis ⬇️

scientific article published on November 1, 2008

No Cerebral or Cervical Venous Insufficiency in US Veterans With Multiple Sclerosis ⬇️

scientific article published on August 8, 2011

Normal intrathecal leukocyte cell number and composition do not decrease the incidence of post-lumbar puncture headache

scientific article published on 30 June 2017

Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis

scientific article

Optic neuritis presenting with amaurosis fugax

scientific article published on 2 September 2009

PDCB does not promote CNS autoimmunity in the context of genetic susceptibility but worsens its outcome

article

PEG minocycline-liposomes ameliorate CNS autoimmune disease

scientific article

Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational study

scientific article published on 09 May 2015

Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling

scientific journal article

Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri) in inflammatory diseases

scientific article published on January 2007

Pharmacological treatment of early multiple sclerosis

scientific article published on January 2008

Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders

scientific article published on July 2006

Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders

scientific article published on August 2006

Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions

scientific article published on February 2007

Primary central nervous system lymphoma in a patient treated with natalizumab

scientific article published in September 2009

Prion protein gene codon 129 modulates clinical course of neurological Wilson disease

scientific article

Prion proteins: physiological functions and role in neurological disorders

scientific article published on 17 August 2007

Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate

scientific article

Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules

scientific article

Quinpramine is a novel compound effective in ameliorating brain autoimmune disease

scientific article

Quinpramine--a promising compound for treating immune-mediated demyelination of the nervous system

scientific article published on June 2010

Reversible Alopecia Associated With Glatiramer Acetate ⬇️

scientific article published on September 1, 2010

Review of teriflunomide and its potential in the treatment of multiple sclerosis

scientific article published on 10 June 2009

Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms ⬇️

scientific article published on November 1, 2009

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab. Evidence for disease heterogeneity

scientific article

Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis

scientific article

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study

scientific article published on 05 July 2016

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

scientific article published on 11 June 2013

Smoking Beyond Multiple Sclerosis Diagnosis: A Risk Factor Still Worth Modifying

scientific article

Statins and the blood-brain barrier: plugging the holes

scientific article published in July 2006

Statins and their potential targets in multiple sclerosis therapy ⬇️

scientific article published on October 1, 2003

Statins as potential therapeutic agents in multiple sclerosis

scientific article published on May 2004

Statins as potential therapeutic agents in neuroinflammatory disorders

scientific article

Statins--a cure-all for the brain?

scientific article

Temporary leukocyte effects in temporal lobe epilepsy?

scientific article published on 23 April 2008

Teriflunomide for the treatment of multiple sclerosis

scientific article published on December 2013

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

scientific article published in November 2002

The combination of interferon-beta and HMG-CoA reductase inhibition in multiple sclerosis: enthusiasm lost too soon?

scientific article published on December 2010

The effects of natalizumab on the innate and adaptive immune system in the central nervous system

scientific article published on 12 May 2008

The future of multiple sclerosis therapy

scientific article

The genetics of natalizumab hypersensitivity: One learns to itch where one can scratch

scientific article

The increasing incidence and prevalence of female multiple sclerosis—A critical analysis of potential environmental factors ⬇️

scientific article published on February 24, 2011

The major histocompatibility complex and antibody-mediated limbic encephalitis

scientific article published on 27 December 2016

The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis ⬇️

scientific article published on May 24, 2013

The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease

scientific article published on December 2002

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

scientific article published on 26 March 2013

Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis

scientific article

Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations

scientific article

Therapeutic potential of small interfering RNA for central nervous system diseases

scientific article

Translational research in neurology and neuroscience 2010: multiple sclerosis

scientific article published on 12 July 2010

Type II monocytes modulate T cell-mediated central nervous system autoimmune disease

scientific article published on 5 August 2007

Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications

scientific article published on May 2009

Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis

scientific article published on 29 March 2016

Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis

scientific article published on 31 March 2016

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder

scientific article

Vestibular hypofunction after monosodium glutamate ingestion: broadening the spectrum of 'Chinese restaurant syndrome'.

scientific article published on 8 April 2016

Visualizing the cause of gray matter atrophy in multiple sclerosis

scientific article published in February 2009

alpha4-Integrin antagonism with natalizumab: effects and adverse effects

scientific article published on December 2008

α4-integrin deficiency in B cells does not affect disease in a T-cell-mediated EAE disease model

article

Paulina is supported by:

About Paulina

Help